{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Eledon Pharmaceuticals Hits New 52-Week Low at $2.31
Eledon Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a challenging year with a notable stock price decline. The company, operating in the Pharmaceuticals & Biotechnology industry, has a market capitalization of USD 154 million and exhibits significant financial strain, as indicated by its negative financial metrics.
Is Eledon Pharmaceuticals, Inc. technically bullish or bearish?
As of June 13, 2025, Eledon Pharmaceuticals, Inc. is in a bearish trend, supported by bearish indicators across MACD, moving averages, Bollinger Bands, and KST, reflecting negative market sentiment.
What does Eledon Pharmaceuticals, Inc. do?
Eledon Pharmaceuticals, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $6 million and a market cap of $168.27 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -83.68%.
How big is Eledon Pharmaceuticals, Inc.?
As of Jun 18, Eledon Pharmaceuticals, Inc. has a market capitalization of 168.27 million and reported net sales of 0.00 million with a net profit of -41.60 million over the last four quarters. Shareholder's funds were 118.14 million, and total assets were 229.44 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
